Related Experiment Video
Updated: May 13, 2025
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Update on hepatitis C virus management
Austin D Peer1, Jennifer C Price
1Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Insights
Hepatitis C virus (HCV) can be cured in most patients with direct-acting antiviral (DAA) therapy. Achieving HCV elimination requires increased screening, simplified treatment access, and addressing barriers for at-risk populations.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) significantly contributes to liver disease and mortality despite effective treatments.
- Direct-acting antiviral (DAA) therapy offers high cure rates for HCV infections.
Purpose of the Study:
- To review current HCV treatment approaches, including simplified algorithms.
- To discuss management strategies for special patient populations.
- To explore future directions for HCV interventions and elimination.
Main Methods:
- Review of current literature on HCV treatment and management.
- Analysis of simplified treatment algorithms for non-specialist providers.
- Examination of advancements in diagnostics and their impact on care access.
Main Results:
- Pan-genotypic DAA regimens demonstrate high efficacy and are manageable by non-specialists.
- Simplified treatment algorithms aid decision-making for treatment-naive patients.
- Point-of-care diagnostics can improve screening and linkage to care, but barriers and stigma persist.
Conclusions:
- HCV elimination is achievable with a comprehensive strategy.
- Increased screening, simplified treatment access, and reduced stigmatization are crucial.
- Addressing healthcare disparities and treatment barriers are vital for meeting elimination targets.
Purpose Of Review:
Despite the efficacy of direct-acting antiviral (DAA) therapy, hepatitis C virus (HCV) remains a significant contributor to liver-related morbidity and mortality. This review summarizes the approach to HCV treatment, the simplified treatment algorithm for most patients, the management of special populations, and future directions for HCV interventions.
Recent Findings:
Pan genotypic DAA regimens have high cure rates and can be managed by nonspecialist providers, and the simplified treatment approach provides a clear algorithm for workup and treatment decisions among treatment-naive patients without decompensated cirrhosis. Additionally, advancements in point of care diagnostics have the potential to further expand access to screening and linkage to care. Despite these breakthroughs, barriers to accessing care and the stigmatization of high-risk populations continue to undercut progress towards HCV elimination. Continued implementation of innovative screening and treatment strategies are required to overcome rising HCV prevalence.
Summary:
HCV cure is achievable for nearly all patients, but reaching HCV elimination goals will require a comprehensive approach that increases screening, expands access to simplified treatment, and avoids stigmatization of at-risk populations. Targeting healthcare disparities and removing barriers to treatment uptake are crucial to achieving elimination targets.
Related Concept Videos
01:10Retrovirus Life Cycles
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:26Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...